Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracerebral Autologous Mesenchymal Stem Cell Transplantation Therapy for Patients with Ischemic Stroke in Chronic Phase: Phase 2a Clinical Trial

NCT06752720 is registered in ClinicalTrials.gov with Hokkaido University Hospital as lead sponsor.

NCT NCT06752720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06752720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracerebral Autologous Mesenchymal Stem Cell Transplantation Therapy for Patients with Ischemic Stroke in Chronic Phase: Phase 2a Clinical Trial
Lead sponsor
Hokkaido University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
December 1, 2024
Completion date
November 30, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, stroke, ischemic, stroke; sequelae